Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: A 14-year Follow-up Study
Conclusions:
We found no evidence of increased risk of subsequent asthma diagnosis among children younger than 3 years of age who received LAIV compared with placebo.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Original Studies Source Type: research
More News: Asthma | Child Development | Children | Clinical Trials | Emergency Medicine | Infectious Diseases | Influenza | Influenza Vaccine | Pediatrics | Study | Vaccines